Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 05:46:59 +0200Wed, 14 Feb 2024 17:06:00 +0100Opinion/decision on a Paediatric investigation plan (PIP): Opsumit, Macitentan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0012/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001032-pip01-10-m05Opinion/decision on a Paediatric investigation plan (PIP): Opsumit, Macitentan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0012/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001032-pip01-10-m05Wed, 14 Feb 2024 17:06:00 +0100Human medicine